Center for Scientific Review; Notice of Closed Meetings, 57866-57867 [2013-22865]
Download as PDF
57866
Federal Register / Vol. 78, No. 183 / Friday, September 20, 2013 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
Final Deadline for Submission of written
comments: Wednesday, October 2, 2013 by
5:00 p.m. e.t.
Please note: The NIMH Office of Autism
Research Coordination (OARC) anticipates
that written public comments received by the
deadline of 5:00 p.m. e.t., Wednesday,
October 2, 2013 will be presented to the
Committee prior to the October 9th meeting
for the Committee’s consideration. Any
written comments received after the October
2, 2013 deadline (between October 3, 2013
and October 8, 2013) will be provided to the
Committee either before or after the meeting,
depending on the volume of comments
received and the staff time required to
process them in accordance with privacy
regulations and other applicable Federal
policies.
Access: Twinbrook Metro (Red Line).
Contact Person: Ms. Lina Perez, Office of
Autism Research Coordination, National
Institute of Mental Health, NIH, 6001
Executive Boulevard, Room 6182A, Bethesda,
MD 20892–9669, Phone: 301–443–6040,
Email: IACCPublicInquiries@mail.nih.gov.
Public Comments
Any member of the public interested in
presenting oral comments to the Committee
must notify the Contact Person listed on this
notice by 5:00 p.m. ET on Friday, September
27, 2013, with their request to present oral
comments at the meeting. Interested
individuals and representatives of
organizations must submit a written/
electronic copy of the oral presentation/
statement including a brief description of the
organization represented by 5:00 p.m. E.T. on
Wednesday, October 2, 2013. Statements
submitted will become a part of the public
record. Only one representative of an
organization will be allowed to present oral
comments and presentations will be limited
to three to five minutes per speaker,
depending on the number of speakers to be
accommodated within the allotted time.
Speakers will be assigned a time to speak in
the order of the date and time when their
request to speak is received, along with the
required submission of the written/electronic
statement by the specified deadline.
In addition, any interested person may
submit written comments to the IACC prior
to the meeting by sending the comments to
the Contact Person listed on this notice by
5:00 p.m. ET on Wednesday, October 2, 2013.
The comments should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person. NIMH
anticipates written public comments received
by 5:00 p.m. E.T., Wednesday, October 2,
2013 will be presented to the Committee
prior to the meeting for the Committee’s
consideration. Any written comments
received after the October 2, 2013 deadline
(between October 3, 2013 and October 8,
2013) will be provided to the Committee
either before or after the meeting, depending
on the volume of comments received and the
staff time required to process them in
accordance with privacy regulations and
other applicable Federal policies. All written
public comments and oral public comment
statements received by the deadlines for both
VerDate Mar<15>2010
17:24 Sep 19, 2013
Jkt 229001
oral and written public comments will be
provided to the IACC for their consideration
and will become part of the public record.
Core Values
In the 2009 IACC Strategic Plan, the IACC
listed the ‘‘Spirit of Collaboration’’ as one of
its core values, stating that, ‘‘We will treat
others with respect, listen to diverse views
with open minds, discuss submitted public
comments, and foster discussions where
participants can comfortably offer opposing
opinions.’’ In keeping with this core value,
the IACC and the NIMH Office of Autism
Research Coordination (OARC) ask that
members of the public who provide public
comments or participate in meetings of the
IACC also seek to treat others with respect
and consideration in their communications
and actions, even when discussing issues of
genuine concern or disagreement.
Remote Access
The meeting will be open to the public
through a conference call phone number and
webcast live on the Internet. Members of the
public who participate using the conference
call phone number will be able to listen to
the meeting but will not be heard. If you
experience any technical problems with the
web cast or conference call, please send an
email to helpdeskiacc@gmail.com or by
phone at 415–652–8023.
Special Accommodations
Individuals who participate in person or by
using these electronic services and who need
special assistance, such as captioning of the
conference call or other reasonable
accommodations, should submit a request to
the Contact Person listed on this notice at
least 5 days prior to the meeting.
Security
As a part of security procedures, attendees
should be prepared to present a photo ID at
the meeting registration desk during the
check-in process. Pre-registration is
recommended. Seating will be limited to the
room capacity and seats will be on a first
come, first served basis, with expedited
check-in for those who are pre-registered.
Meeting schedule subject to change.
Information about the IACC is available on
the Web site: https://www.iacc.hhs.gov.
Dated: September 12, 2013.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–22867 Filed 9–19–13; 8:45 am]
BILLING CODE 4140–01–P
The meetings will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended.
The contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Sample Biorepository and Laboratory Center
for Myeloid Dysplasia Diseases.
Date: October 10, 2013.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Doubletree Hotel Bethesda
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Michael P Reilly, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7200, Bethesda, MD 20892, 301–496–9659,
reillymp@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Data Center for Myeloid Dysplasia Diseases.
Date: October 10, 2013.
Time: 12:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Doubletree Hotel Bethesda
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Michael P Reilly, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7200, Bethesda, MD 20892, 301–496–9659,
reillymp@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: September 13, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–22866 Filed 9–19–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\20SEN1.SGM
20SEN1
Federal Register / Vol. 78, No. 183 / Friday, September 20, 2013 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
amended (5 U.S.C. App.),notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in
sections552b(c)(4) and 552b(c)(6), Title
5 U.S.C., as amended. The grant
applications and thediscussions could
disclose confidential trade secrets or
commercial property such as
patentablematerial, and personal
information concerning individuals
associated with the grant
applications,the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group;
Skeletal Biology Structure and Regeneration
Study Section.
Date: October 8–9, 2013.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Admiral Fell Inn, 888 South
Broadway, Baltimore, MD 21231.
Contact Person: Daniel F McDonald, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4110,
MSC 7814, Bethesda, MD 20892, (301) 435–
1215, mcdonald@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Risk,
Prevention, and Intervention for Addictions
Overflow.
Date: October 17–18, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Dupont Hotel, 1500 New
Hampshire Avenue NW., Washington, DC
20036.
Contact Person: Kristen Prentice, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3112,
MSC 7808, Bethesda, MD 20892, 301–496–
0726, prenticekj@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Sensory and Motor
Neurosciences, Cognition and Perception.
Date: October 17–18, 2013
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Washington DC
Dupont, 1143 New Hampshire Avenue NW.,
Washington, DC 20037.
Contact Person: Sharon S Low, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5104,
MSC 5104, Bethesda, MD 20892–5104, 301–
237–1487, lowss@csr.nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group;
Gastrointestinal Mucosal Pathobiology Study
Section
Date: October 17, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Mar<15>2010
17:24 Sep 19, 2013
Jkt 229001
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Rd. NW.,
Washington, DC.
Contact Person: Peter J Perrin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180,
MSC 7818, Bethesda, MD 20892, (301) 435–
0682, perrinp@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Drug Discovery and Mechanisms of
Antimicrobial Resistance Study Section.
Date: October 17–18, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Guangyong Ji, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3188,
MSC 7808, Bethesda, MD 20892, 301–435–
1146, jig@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group,
Pathogenic Eukaryotes Study Section.
Date: October 17–18, 2013.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Gunter Hotel, 205 East
Houston Street, San Antonio, TX 78205.
Contact Person: Tera Bounds, DVM, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3198,
MSC 7808, Bethesda, MD 20892, 301 435–
2306, boundst@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Virology—B Study Section.
Date: October 17–18, 2013.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Gunter Hotel, 205 East
Houston St., San Antonio, TX 78205.
Contact Person: John C Pugh, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1206,
MSC 7808, Bethesda, MD 20892, (301) 435–
2398, pughjohn@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Pathophysiology and Clinical Studies of
Osteonecrosis of the Jaw.
Date: October 17, 2013.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Yi-Hsin Liu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214,
MSC 7814, Bethesda, MD 20892, 301–435–
1781, liuyh@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Mechanisms
of Gene Regulation.
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
57867
Date: October 17, 2013.
Time: :00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Richard A Currie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1108,
MSC 7890, Bethesda, MD 20892, (301) 435–
1219, currieri@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 16, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–22865 Filed 9–19–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Digestive Diseases
Centers.
Date: November 21–22, 2013.
Time: 6:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Maria E. Davila-Bloom,
Ph.D., Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 758, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7637, davila-bloomm@
extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
E:\FR\FM\20SEN1.SGM
20SEN1
Agencies
[Federal Register Volume 78, Number 183 (Friday, September 20, 2013)]
[Notices]
[Pages 57866-57867]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-22865]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
[[Page 57867]]
amended (5 U.S.C. App.),notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and thediscussions could
disclose confidential trade secrets or commercial property such as
patentablematerial, and personal information concerning individuals
associated with the grant applications,the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Musculoskeletal, Oral and Skin Sciences
Integrated Review Group; Skeletal Biology Structure and Regeneration
Study Section.
Date: October 8-9, 2013.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Admiral Fell Inn, 888 South Broadway, Baltimore, MD
21231.
Contact Person: Daniel F McDonald, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4110, MSC 7814, Bethesda, MD
20892, (301) 435-1215, mcdonald@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Risk, Prevention, and Intervention for Addictions Overflow.
Date: October 17-18, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Dupont Hotel, 1500 New Hampshire Avenue NW.,
Washington, DC 20036.
Contact Person: Kristen Prentice, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3112, MSC 7808, Bethesda, MD
20892, 301-496-0726, prenticekj@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Sensory and Motor Neurosciences, Cognition and
Perception.
Date: October 17-18, 2013
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Renaissance Washington DC Dupont, 1143 New Hampshire
Avenue NW., Washington, DC 20037.
Contact Person: Sharon S Low, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5104, MSC 5104, Bethesda, MD 20892-5104, 301-
237-1487, lowss@csr.nih.gov.
Name of Committee: Digestive, Kidney and Urological Systems
Integrated Review Group; Gastrointestinal Mucosal Pathobiology Study
Section
Date: October 17, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Rd. NW., Washington, DC.
Contact Person: Peter J Perrin, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180, MSC 7818, Bethesda, MD
20892, (301) 435-0682, perrinp@csr.nih.gov.
Name of Committee: Infectious Diseases and Microbiology
Integrated Review Group; Drug Discovery and Mechanisms of
Antimicrobial Resistance Study Section.
Date: October 17-18, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Guangyong Ji, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3188, MSC 7808, Bethesda, MD 20892, 301-435-
1146, jig@csr.nih.gov.
Name of Committee: Infectious Diseases and Microbiology
Integrated Review Group, Pathogenic Eukaryotes Study Section.
Date: October 17-18, 2013.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Gunter Hotel, 205 East Houston Street, San
Antonio, TX 78205.
Contact Person: Tera Bounds, DVM, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3198, MSC 7808, Bethesda, MD
20892, 301 435-2306, boundst@csr.nih.gov.
Name of Committee: Infectious Diseases and Microbiology
Integrated Review Group; Virology--B Study Section.
Date: October 17-18, 2013.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Gunter Hotel, 205 East Houston St., San Antonio,
TX 78205.
Contact Person: John C Pugh, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 1206, MSC 7808, Bethesda, MD 20892, (301) 435-
2398, pughjohn@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Pathophysiology and Clinical Studies of Osteonecrosis of the
Jaw.
Date: October 17, 2013.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select),
8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Yi-Hsin Liu, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4214, MSC 7814, Bethesda, MD 20892, 301-435-
1781, liuyh@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Mechanisms of Gene Regulation.
Date: October 17, 2013.
Time: :00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Richard A Currie, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1108, MSC 7890, Bethesda, MD
20892, (301) 435-1219, currieri@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: September 16, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-22865 Filed 9-19-13; 8:45 am]
BILLING CODE 4140-01-P